ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease

Biomarkers are the only feasible way to detect and monitor presymptomatic Alzheimer's disease (AD). No single biomarker can predict future cognitive decline with an acceptable level of accuracy. In addition to designing powerful multimodal diagnostic platforms, a careful investigation of the ma...

Full description

Bibliographic Details
Main Authors: Apostolova, Liana G., Hwang, Kristy S., Kohannim, Omid, Avila, David, Elashoff, David, Jack, Clifford R., Shaw, Leslie, Trojanowski, John Q., Weiner, Michael W., Thompson, Paul M.
Format: Online
Language:English
Published: Elsevier 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952354/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952354/

Similar Items